E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/26/2011 in the Prospect News PIPE Daily.

Arrowhead plans $18.51 million share purchase, preferreds, stock sales

Lincoln Park Capital Fund to buy company common stock over three years

By Devika Patel

Knoxville, Tenn., Oct. 26 - Arrowhead Research Corp. arranged a $15 million stock purchase agreement with Lincoln Park Capital Fund, LLC on Oct. 20, according to an 8-K filed Wednesday with the Securities and Exchange Commission. It also negotiated a $1.02 million private placement of series A preferred convertible stock on Oct. 21 and Oct. 24, along with a $2.5 million placement of common stock on Oct. 21 for a total of $18.51 million.

The company will sell common shares to Lincoln Park over three years. The purchase price of the shares will be based on the prevailing market prices without any fixed discount.

The company has already paid a $269,500 commitment fee in stock valued at $0.391 per share and will pay an additional commitment fee of up to $346,500 as the facility is used, which will also be paid in stock valued at $0.391 per share.

In the preferreds sale, the company will sell 1,015 preferreds at $1,000.00 apiece by Oct. 26. Each preferred will automatically convert into 2,631.58 common shares after the company receives shareholder approval for the conversion.

In the last placement, the company will sell 6.75 million common shares at $0.37 per share. The price per share is a 13.95% discount to the Oct. 20 closing share price of $0.43.

Settlement for this last placement and for the preferreds sale is expected Oct. 26.

Proceeds will be used for general operations.

Located in Pasadena, Calif., Arrowhead develops nanotechnology used in life sciences, electronics and energy.

Issuer:Arrowhead Research Corp.
Issue:Stock purchase agreement, series A preferred convertible stock
Amount:$18,512,500
Warrants:No
Stock symbol:Nasdaq: ARWR
Market capitalization:$39.52 million
Stock purchase agreement
Amount:$15 million
Tenor:Three years
Investor:Lincoln Park Capital Fund, LLC
Price:No fixed discount
Fees:$616,000
Pricing date:Oct. 20
Stock price:$0.43 at close Oct. 20
Preferred stock
Amount:$1,015,000
Preferreds:1,015
Price:$1,000
Conversion ratio:2,631.58 common shares per preferred
Pricing dates:Oct. 21, Oct. 24
Settlement date:Oct. 26
Stock price:$0.46 at close Oct. 21
Common stock
Amount:$2,497,500
Shares:6.75 million
Price:$0.37
Pricing date:Oct. 21
Settlement date:Oct. 26
Stock price:$0.46 at close Oct. 21

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.